Thermo Fisher Scientific Inc. (TMO) to Distribute Quarterly Dividend of $0.19 on October 15th
Thermo Fisher Scientific Inc. (NYSE:TMO) announced a quarterly dividend on Thursday, July 11th, RTT News reports. Stockholders of record on Tuesday, September 17th will be paid a dividend of 0.19 per share by the medical research company on Tuesday, October 15th. This represents a $0.76 annualized dividend and a dividend yield of 0.26%.
Thermo Fisher Scientific has raised its dividend by an average of 3.2% per year over the last three years. Thermo Fisher Scientific has a payout ratio of 6.9% indicating that its dividend is sufficiently covered by earnings. Analysts expect Thermo Fisher Scientific to earn $13.55 per share next year, which means the company should continue to be able to cover its $0.76 annual dividend with an expected future payout ratio of 5.6%.
Shares of TMO stock opened at $290.94 on Friday. The company has a fifty day moving average of $285.80. The company has a current ratio of 1.69, a quick ratio of 1.16 and a debt-to-equity ratio of 0.61. The firm has a market cap of $118.21 billion, a price-to-earnings ratio of 25.86, a price-to-earnings-growth ratio of 1.94 and a beta of 1.10. Thermo Fisher Scientific has a one year low of $207.97 and a one year high of $305.45.
Several analysts recently commented on the company. Argus boosted their price target on Thermo Fisher Scientific from $285.00 to $310.00 and gave the company a “buy” rating in a research note on Wednesday, May 1st. UBS Group lowered AGL Energy to a “sell” rating in a research note on Thursday, May 23rd. Needham & Company LLC reaffirmed a “strong-buy” rating and issued a $315.00 price target (up previously from $313.00) on shares of Thermo Fisher Scientific in a research note on Thursday, May 23rd. BTIG Research boosted their price target on Thermo Fisher Scientific to $320.00 and gave the company a “buy” rating in a research note on Thursday, May 23rd. Finally, Deutsche Bank decreased their price target on Uniti Group from $20.00 to $8.00 and set a “hold” rating on the stock in a research note on Friday, March 22nd. Two investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of $295.92.
In other news, Director C Martin Harris sold 275 shares of the business’s stock in a transaction on Wednesday, June 5th. The stock was sold at an average price of $270.73, for a total transaction of $74,450.75. Following the completion of the sale, the director now owns 6,433 shares in the company, valued at $1,741,606.09. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Marc N. Casper sold 50,713 shares of the business’s stock in a transaction on Tuesday, April 30th. The stock was sold at an average price of $273.21, for a total value of $13,855,298.73. Following the sale, the chief executive officer now owns 302,193 shares of the company’s stock, valued at approximately $82,562,149.53. The disclosure for this sale can be found here. In the last three months, insiders sold 53,488 shares of company stock worth $14,600,474. Insiders own 0.45% of the company’s stock.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.
Featured Story: Dividend Achievers
Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.